MONDAY, July 26, 2021 (HealthDay News) — As a new school year approaches, U.S. parents are nearly evenly split on whether they’ll vaccinate their young kids when a COVID-19 vaccine is approved for their age group, a new survey finds. “It’s important that parents and providers don’t wait for fullContinue Reading

MONDAY, July 26, 2021 (HealthDay News) — Accidental exposure to fentanyl pain patches is putting children’s lives at risk, the U.S. Food and Drug Administration warns. Fentanyl is a powerful opioid pain reliever; so powerful that fentanyl patches are typically only prescribed to patients who require round-the-clock, long-term pain relief,Continue Reading

FRIDAY, July 23, 2021 (HealthDay News) — The controversial new Alzheimer’s drug Aduhelm is creating something of a civil war in medicine, as health networks, hospitals, insurers and individual doctors weigh impending discussions with patients about whether they should take the medication. Many doctors believe the U.S. Food and DrugContinue Reading

FRIDAY, July 23, 2021 (HealthDay News) — A drug that eases hallucinations in people with Parkinson’s disease may be able to do the same for those with dementia, a new clinical trial finds. The medication, called Nuplazid (pimavanserin), is already approved in the United States for treating hallucinations and delusionsContinue Reading

THURSDAY, July 22, 2021 (HealthDay News) — Pfizer’s coronavirus vaccine provides surprisingly robust protection against the highly infectious Delta variant of COVID-19 — but only if you’ve gotten both doses. Fresh data out of England shows that two doses of the messenger RNA (mRNA) vaccine is 88% effective in protectingContinue Reading

THURSDAY, July 22, 2021 (HealthDay News) — A proposed $26 billion settlement on opioid-related lawsuits has been reached with four large drug companies, a group of state attorneys general announced Wednesday. If enough states sign on to the deal with the country’s three major drug distributors — Cardinal Health, AmerisourceBergenContinue Reading